This study, being conducted in South Africa, is similar to ImmunityBio’s U.S.-based trial QUILT 3.092, a phase 1 open-label study of CD19 t-haNK as a single agent and in combination with the company’s ...
Eschewing the notion that less is more with a vengeance, Parker Finn’s “Smile 2” is everything his surprise 2022 hit was not. Loud, bloated and gratuitous, the sequel stumbles into ...
A second person, traveling with the man on a separate watercraft, declined medical treatment at the scene, according to a news release from Nunda Rural Fire Protection District. The first responders ...
A new study being presented at this year’s ACAAI Annual Scientific Meeting showed that, in Chicago, there has been a significant increase in sensitization to pollens and molds in patients with nasal ...